Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
Moodys
McKinsey
Colorcon

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR DIFLUNISAL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Diflunisal

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00294671 ↗ The Effect of Diflunisal on Familial Amyloidosis Completed Food and Drug Administration (FDA) Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA Office of Orphan Products Development (OOPD); National Institute of Neurological Disorders and Stroke (NINDS)
NCT00294671 ↗ The Effect of Diflunisal on Familial Amyloidosis Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA Office of Orphan Products Development (OOPD); National Institute of Neurological Disorders and Stroke (NINDS)
NCT00294671 ↗ The Effect of Diflunisal on Familial Amyloidosis Completed Boston University Phase 2/Phase 3 2006-02-01 The purpose of this study is to determine if diflunisal can prevent progressive lower leg nerve damage in patients with familial amyloidosis polyneuropathy. Funding Source - FDA Office of Orphan Products Development (OOPD); National Institute of Neurological Disorders and Stroke (NINDS)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Diflunisal

Condition Name

Condition Name for Diflunisal
Intervention Trials
Hepatitis C 1
HIV Infection 1
Amyloidosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Diflunisal
Intervention Trials
Amyloidosis 2
Amyloid Neuropathies, Familial 2
Polyneuropathies 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Diflunisal

Trials by Country

Trials by Country for Diflunisal
Location Trials
United States 4
Sweden 2
United Kingdom 2
Canada 1
Japan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Diflunisal
Location Trials
Kansas 1
New York 1
Minnesota 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Diflunisal

Clinical Trial Phase

Clinical Trial Phase for Diflunisal
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Diflunisal
Clinical Trial Phase Trials
Completed 5
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Diflunisal

Sponsor Name

Sponsor Name for Diflunisal
Sponsor Trials
Umeå University 1
University of Liverpool 1
University of Turin, Italy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Diflunisal
Sponsor Trials
Other 8
Industry 1
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Medtronic
Colorcon
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.